You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (15)

Journals (0)

1-10 of 15 results for brigatinib

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Brigatinib-associated autoimmune hepatitis: A case report

Retricted access

Case report

First published 2023

Brigatinib-associated autoimmune hepatitis: A case report

Mahmut Buyuksimsek, Ali Ogul, Abdullah Evren Yetisir [...]

Journal of Oncology Pharmacy Practice

Select article: Comparative analysis of alectinib and brigatinib in real-world treatment of advanced NSCLC with ALK rearrangements

Open access

Research article

First published 2025

Comparative analysis of alectinib and brigatinib in real-world treatment of advanced NSCLC with ALK rearrangements

Kyuhwan Kim, Kyu Yean Kim, Hye Seon Kang [...]

Therapeutic Advances in Medical Oncology

Select article: Brigatinib: Novel ALK Inhibitor for Non–Small-Cell Lung Cancer

Retricted access

Review article

First published 2019-6

Brigatinib: Novel ALK Inhibitor for Non–Small-Cell Lung Cancer

Sara A. Spencer, Angela C. Riley, Adia Matthew [...]

Annals of Pharmacotherapy

Select article: Experiences of the combined use of Favipiravir in patients using Lorlatinib and Brigatinib

Retricted access

Case report

First published 2022-12

Experiences of the combined use of Favipiravir in patients using Lorlatinib and Brigatinib

Mustafa Buyukkor, Fatih Tay, Ozturk Ates

Journal of Oncology Pharmacy Practice

Select article: Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L)

Open access

Research article

First published 2024

Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L)

Yuichi Ozawa, Yasuhiro Koh, Tetsunari Hase [...]

Therapeutic Advances in Medical Oncology

Select article: Brigatinib is a cost-effective treatment in first-line anaplastic lymphoma kinase mutation-positive (ALK + ) advanced non-small cell lung cancer (NSCLC) with brain metastases

Retricted access

Research article

First published 2022-4

Brigatinib is a cost-effective treatment in first-line anaplastic lymphoma kinase mutation-positive (ALK + ) advanced non-small cell lung cancer (NSCLC) with brain metastases

Jacopo Giuliani

Journal of Oncology Pharmacy Practice

Select article: First-line treatments for patients with advanced ALK gene rearrangements in NSCLC: a systematic review and network meta-analysis

Open access

Research article

First published 2022-11

First-line treatments for patients with advanced ALK gene rearrangements in NSCLC: a systematic review and network meta-analysis

Jiahao Tao, Chuangjie Zheng, Cuifen Zhang [...]

Journal of International Medical Research

Select article: Remarkable Response to Ceritinib and Brigatinib in an Anaplastic Lymphoma Kinase-Rearranged Anaplastic Thyroid Carcinoma Previously Treated with Crizotinib

Retricted access

Letter

First published 2020-02

Remarkable Response to Ceritinib and Brigatinib in an Anaplastic Lymphoma Kinase-Rearranged Anaplastic Thyroid Carcinoma Previously Treated with Crizotinib

Laura Leroy, Benjamin Bonhomme, Sylvestre Le Moulec [...]

Thyroid®

Select article: Cost-Effectiveness Analysis of 6 Tyrosine Kinase Inhibitors as First-Line Treatment for ALK-Positive NSCLC in China

Open access

Research article

First published 2024

Cost-Effectiveness Analysis of 6 Tyrosine Kinase Inhibitors as First-Line Treatment for ALK-Positive NSCLC in China

Meiling Zhang, Bei Zheng, Wenjuan Yang [...]

Clinical Medicine Insights: Oncology

Select article: Front-line treatment for advanced non-small-cell lung cancer and ALK fusion: a network meta-analysis

Open access

Research article

First published 2022

Front-line treatment for advanced non-small-cell lung cancer and ALK fusion: a network meta-analysis

Yaokai Wen, Tao Jiang, Xiangrong Wu [...]

Therapeutic Advances in Medical Oncology

1
2
10 / page

Article type

Publication date

Subjects

Access